International Psoriasis Council
Advancing Knowledge. Improving Care.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis
Discover how the 2025 IPC International Fellows navigated a year of global learning, collaboration, and growth to help advance psoriasis
Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing psoriasis treatment in this IPC-led symposium
National cohort data from Taiwan reveal a strong link between immune checkpoint inhibitor (ICI) therapy and new-onset psoriasis in cancer
Discover the new free psoriasis course on WHOAcademy, created by IPC and IFPA for the WHO. Enhance your knowledge of
The 2024 IPC International Fellows reflect on their global dermatological journey, sharing their unique experiences, challenges, and achievements from a
Uncover the true impact of psoriasis and learn about critical steps to improve diagnosis, treatment, and patient support in the
Learn about the new global diagnostic criteria for Generalized Pustular Psoriasis as set by the International Psoriasis Council. Discover the
Highlighting a decade of psoriasis advocacy. IPC is pleased to join IFPA in celebrating the 20th anniversary of the World
Join Dr. Mahira Hamdy El Sayed, a dedicated dermatologist, esteemed Professor, and a crucial member of the International Psoriasis Council
Discover the latest additions to the IPC’s Board of Directors, key psoriasis leaders, André Carvalho and Amy Paller. Get to
Explore the global dermatological journey of the 2023 IPC International Fellows. Learn about their diverse experiences, challenges, and triumphs as
Join Dr. Joel Gelfand, MD, MSCE, a dermatologist, epidemiologist, and tenured professor at the University of Pennsylvania, serving as the
Read the latest breakthroughs in psoriasis research with IPC Councilor Dr. Helen Young as she examines a groundbreaking GWAS meta-analysis.
Join Dr. Claudia de la Cruz, a dermatologist from Santiago, Chile, and Secretary of the International Psoriasis Council, as she
Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in Berlin, Germany. This
Learn the dynamics of psoriasis treatments, emphasizing patient adherence challenges. From evolving therapies to oral and biologic agents, understand real-world
IPC stands for accessible treatment and universal healthcare on World Psoriasis Day and beyond. Gain insights from experts on the
Explore the impact of psoriasis on global public health and the latest addition of methotrexate for managing moderate to severe
The University of Oxford seeks 2000 psoriasis volunteers for a groundbreaking study exploring the link between the skin condition and
Discover the latest updates on psoriasis from the World Congress of Dermatology (WCD) 2023, hosted in Singapore from July 3–8.
This blog post provides a comprehensive overview of psoriasis in individuals with skin of color. It explores the prevalence of
The Society of Investigative Dermatology (SID) Annual Meeting returned to an in-person format in 2022 for the first time in
It is not fully understood the impact that COVID-19 has on psoriasis patients.
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.